Skip to main content
eScholarship
Open Access Publications from the University of California

UC San Diego

UC San Diego Electronic Theses and Dissertations bannerUC San Diego

Early Acquisition of CD8+ T Cell Exhaustion State Is Regulated by Ezh2

No data is associated with this publication.
Abstract

During infection with an acute microbial infection, responding CD8+ T cells give rise to effector cells that provide acute host defense and memory cells that provide sustained protection. An alternative outcome is exhaustion, a state of T cell dysfunction that occurs in the context of chronic infections and cancer. Although it is evident that exhausted CD8+ T cells (TEX) are phenotypically and molecularly distinct from effector and memory CD8+ T cells, the factors regulating the earliest events in the differentiation process of TEX cells remain incompletely understood. Here we performed single-cell RNA-sequencing and single-cell ATAC-sequencing of CD8+ T cells responding to LCMV-Armstrong (LCMV-Arm) or LCMV-Clone 13 (LCMV-Cl13). Compared to CD8+ T cells that had undergone their first division in response to LCMV-Arm (Div1ARM) cells, CD8+ T cells that had undergone their first division in response to LCMV-Cl13 (Div1CL13) expressed higher levels of genes encoding transcription factors that have been previously reported to promote exhaustion, along with Ezh2, the catalytic component of the polycomb repressive complex 2 (PRC2) complex which mediates epigenetic silencing. Modulation of Ezh2 by genetic deletion or retroviral overexpression approaches resulted in decreased or increased expression, respectively, of exhaustion-associated molecules by CD8+ T cells responding to LCMV-Cl13. Taken together, these findings indicate that acquisition of phenotypic, transcriptional, and epigenetic features associated with T cell exhaustion can occur earlier than previously appreciated and raise the possibility that TEX cells may not need to transit through an effector intermediate state.

Main Content

This item is under embargo until January 6, 2025.